World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
47
Citations
9507
World Ranking
4763
National Ranking
1838

Victoria R. Polonis publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Victoria R. Polonis sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 152 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Victoria R. Polonis D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Victoria R. Polonis sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 47 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Victoria R. Polonis is affiliated with the Walter Reed Army Institute of Research in the United States. Their research spans multiple disciplines within medicine and immunology, particularly focusing on infectious diseases and virology.

The primary fields of study for Victoria R. Polonis include Medicine and Immunology and Microbiology, with notable contributions in the subfields of Infectious Diseases, Virology, Immunology, Molecular Biology, and Epidemiology.

The main topics addressed in their research cover HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research, Immune Cell Function and Interaction, T-cell and B-cell Immunology, Monoclonal and Polyclonal Antibodies Research, COVID-19 Clinical Research Studies, and SARS-CoV-2 detection and testing.

Their recent publications demonstrate a focus on vaccine development and immune response to viral infections. Selected papers include:

  • SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity, 2021, Cell Reports
  • A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates, 2022, Science Translational Medicine
  • Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption, 2020, Nature Medicine
  • A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge, 2021, npj Vaccines
  • Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques, 2021, Proceedings of the National Academy of Sciences

Frequent co-authors who have collaborated with Victoria R. Polonis include Lindsay Wieczorek, Nelson L. Michael, Shelly J. Krebs, Michelle Zemil, and Vincent Dussupt.

Their work has been published regularly in specific scientific venues, reflecting an ongoing engagement with the immunology and virology research communities. Common publication venues include bioRxiv (Cold Spring Harbor Laboratory), PLoS Pathogens, Frontiers in Immunology, Nature Communications, and Journal of Virology.

Best Publications

  • Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

    Ming Li;Feng Gao;John R. Mascola;Leonidas Stamatatos

  • Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.

    Michael S. Seaman;Holly Janes;Natalie Hawkins;Lauren E. Grandpre

  • Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular env Clones from Acute and Early Heterosexually Acquired Infections in Southern Africa

    Ming Li;Jesus F. Salazar-Gonzalez;Cynthia A. Derdeyn;Lynn Morris

  • Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials

    David C. Montefiori;Chitraporn Karnasuta;Ying Huang;Hasan Ahmed

  • Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines.

    John R. Mascola;Patricia D'Souza;Peter Gilbert;Beatrice H. Hahn

  • A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus Infection

    Redfield Rr;Birx Dl;Ketter N;Tramont E

  • Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades

    Miroslaw K. Gorny;Constance Williams;Barbara Volsky;Kathy Revesz

  • Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC

    Tar A. G. Edmonds;Haitao Ding;Xing Yuan;Qing Wei

  • A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates

    Unknown

  • Biologic and Genetic Characterization of a Panel of 60 Human Immunodeficiency Virus Type 1 Isolates, Representing Clades A, B, C, D, CRF01_AE, and CRF02_AG, for the Development and Assessment of Candidate Vaccines

    Bruce K. Brown;Janice M. Darden;Sodsai Tovanabutra;Tamara Oblander

  • Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults

    Sorachai Nitayaphan;Punnee Pitisuttithum;Chitraporn Karnasuta;Chirapa Eamsila

  • Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.

    Victoria R. Polonis;Bruce K. Brown;Andrew Rosa Borges;Susan Zolla-Pazner

  • Development of Calibrated Viral Load Standards for Group M Subtypes of Human Immunodeficiency Virus Type 1 and Performance of an Improved AMPLICOR HIV-1 MONITOR Test with Isolates of Diverse Subtypes

    Nelson L. Michael;Steven A. Herman;Shirley Kwok;Kimberly Dreyer

  • SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity

    Unknown

  • Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1

    T.C. Vancott;V.R. Polonis;L.D. Loomis;N.L. Michael

  • Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1.

    T C VanCott;F R Bethke;V R Polonis;M K Gorny

  • International network for comparison of HIV neutralization assays: the NeutNet report.

    Eva Maria Fenyö;Alan Heath;Stefania Dispinseri;Harvey Holmes

  • A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost.

    Prasert Thongcharoen;Vinai Suriyanon;Robert M Paris;Chirasak Khamboonruang

  • Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1.

    Shengqiang Li;Victoria Polonis;Hidecki Isobe;Habib Zaghouani

  • Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models.

    Bruce K. Brown;Lindsay Wieczorek;Eric Sanders-Buell;Andrew Rosa Borges

  • Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania.

    Muhammad Bakari;Said Aboud;Said Aboud;Charlotta Nilsson;Joel Francis

  • In-Depth Analysis of a Heterosexually Acquired Human Immunodeficiency Virus Type 1 Superinfection: Evolution, Temporal Fluctuation, and Intercompartment Dynamics from the Seronegative Window Period through 30 Months Postinfection

    F. E. McCutchan;M. Hoelscher;S. Tovanabutra;S. Piyasirisilp

Frequent Co-Authors

Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
David C. Montefiori
David C. Montefiori Duke University
Merlin L. Robb
Merlin L. Robb Walter Reed Army Institute of Research
Deborah L. Birx
Deborah L. Birx Centers for Disease Control and Prevention
Jerome H. Kim
Jerome H. Kim Walter Reed Army Institute of Research
Carl R. Alving
Carl R. Alving Walter Reed Army Institute of Research
M. Gordon Joyce
M. Gordon Joyce Henry M. Jackson Foundation
Alexander R. A. Anderson
Alexander R. A. Anderson Moffitt Cancer Center
Morgane Rolland
Morgane Rolland Henry M. Jackson Foundation
John C. Kappes
John C. Kappes University of Alabama at Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Microbiology in the USA, exploring complementary online degrees can expand career opportunities. Health Information Management (HIM) is one such field, blending healthcare with data management. Professionals can track patient data efficiently to improve outcomes. Programs offering a master in health information management salary show competitive earning potential, making it an attractive path.

Students seeking reputable programs should consider a cahiim accredited him degree online, ensuring quality education recognized nationwide. This accreditation is vital for job prospects in the growing health information sector.

For quicker entry into healthcare administration, many pursue a medical billing and coding certificate online accelerated. These certificates open doors to key roles handling medical records and insurance processes, often with flexible schedules tailored to busy learners.

Finally, those interested in direct clinical roles can explore what medical degree can i get online to find accredited programs offering online pathways in health science fields. This knowledge helps microbiology students diversify their expertise and choose a career that fits their interests and lifestyle.

Best Scientists Citing Victoria R. Polonis

Trending Scientists

Recently Published Articles